IMIPRAMINE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for imipramine hydrochloride and what is the scope of patent protection?
Imipramine hydrochloride
is the generic ingredient in five branded drugs marketed by Novartis, Chartwell, Leading, Lederle, Oxford Pharms, Par Pharm, Roxane, Sandoz, Specgx Llc, Strides Pharma, Sun Pharm Industries, Teva, Usl Pharma, Vangard, Watson Labs, West Ward, Abbott, Alra, and Sanofi Aventis Us, and is included in forty NDAs. Additional information is available in the individual branded drug profile pages.There are ten drug master file entries for imipramine hydrochloride. Twelve suppliers are listed for this compound.
Summary for IMIPRAMINE HYDROCHLORIDE
US Patents: | 0 |
Tradenames: | 5 |
Applicants: | 19 |
NDAs: | 40 |
Drug Master File Entries: | 10 |
Finished Product Suppliers / Packagers: | 12 |
Raw Ingredient (Bulk) Api Vendors: | 111 |
Clinical Trials: | 52 |
Patent Applications: | 1,486 |
What excipients (inactive ingredients) are in IMIPRAMINE HYDROCHLORIDE? | IMIPRAMINE HYDROCHLORIDE excipients list |
DailyMed Link: | IMIPRAMINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for IMIPRAMINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Wright State University | Phase 1 |
Benha University | N/A |
Wright State Physicians | Phase 1 |
Pharmacology for IMIPRAMINE HYDROCHLORIDE
Drug Class | Tricyclic Antidepressant |
Anatomical Therapeutic Chemical (ATC) Classes for IMIPRAMINE HYDROCHLORIDE
US Patents and Regulatory Information for IMIPRAMINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lederle | IMIPRAMINE HYDROCHLORIDE | imipramine hydrochloride | TABLET;ORAL | 086269-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | IMIPRAMINE HYDROCHLORIDE | imipramine hydrochloride | TABLET;ORAL | 085877-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Abbott | JANIMINE | imipramine hydrochloride | TABLET;ORAL | 017895-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | IMIPRAMINE HYDROCHLORIDE | imipramine hydrochloride | TABLET;ORAL | 085878-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sun Pharm Industries | IMIPRAMINE HYDROCHLORIDE | imipramine hydrochloride | TABLET;ORAL | 081049-001 | Jun 5, 1990 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.